Viewing Study NCT01908192


Ignite Creation Date: 2025-12-24 @ 3:52 PM
Ignite Modification Date: 2026-01-04 @ 7:02 AM
Study NCT ID: NCT01908192
Status: TERMINATED
Last Update Posted: 2024-05-09
First Post: 2013-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBenĀ®
Sponsor: SyneuRx International (Taiwan) Corp
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module